My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Various WA Local Governments 9/21/2022
>
Contracts
>
Agreement
>
Interlocal Agreements
>
Various WA Local Governments 9/21/2022
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
2/26/2024 7:10:18 AM
Creation date
9/30/2022 2:40:54 PM
Metadata
Fields
Template:
Contracts
Contractor's Name
Various WA Local Governments
Approval Date
9/21/2022
Council Approval Date
9/14/2022
Department
Legal
Department Project Manager
Ramsey Ramerman
Subject / Project Title
Settlement Agreement Opioid Distributors
Tracking Number
0003472
Total Compensation
$0.00
Contract Type
Agreement
Contract Subtype
Interlocal Agreements
Retention Period
6 Years Then Destroy
Imported from EPIC
No
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
149
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
FINAL AGREEMENT 3.25.22 <br /> Schedule B <br /> Approved Uses <br /> Support treatment of Opioid Use Disorder(OUD) and any co-occurring Substance Use Disorder <br /> or Mental Health(SUD/MH)conditions through evidence-based or evidence-informed programs <br /> or strategies that may include,but are not limited to,the following: <br /> PART ONE: TREATMENT <br /> A. TREAT OPIOID USE DISORDER(OUD) <br /> Support treatment of Opioid Use Disorder("OUD") and any co-occurring Substance Use <br /> Disorder or Mental Health("SUD/MH") conditions through evidence-based or evidence- <br /> informed programs or strategies that may include,but are not limited to,those that:15 <br /> 1. Expand availability of treatment for OUD and any co-occurring SUD/MH <br /> conditions, including all forms of Medication-Assisted Treatment("MAT') <br /> approved by the U.S. Food and Drug Administration. <br /> 2. Support and reimburse evidence-based services that adhere to the American <br /> Society of Addiction Medicine("ASAM") continuum of care for OUD and any co- <br /> occurring SUD/MH conditions. <br /> 3. Expand telehealth to increase access to treatment for OUD and any co-occurring <br /> SUD/MH conditions, including MAT, as well as counseling,psychiatric support, <br /> and other treatment and recovery support services. <br /> 4. Improve oversight of Opioid Treatment Programs ("OTPs")to assure evidence- <br /> based or evidence-informed practices such as adequate methadone dosing and low <br /> threshold approaches to treatment. <br /> 5. Support mobile intervention,treatment, and recovery services, offered by <br /> qualified professionals and service providers, such as peer recovery coaches, for <br /> persons with OUD and any co-occurring SUD/MH conditions and for persons <br /> who have experienced an opioid overdose. <br /> 6. Provide treatment of trauma for individuals with OUD (e.g.,violence, sexual <br /> assault,human trafficking, or adverse childhood experiences) and family <br /> members(e.g., surviving family members after an overdose or overdose fatality), <br /> and training of health care personnel to identify and address such trauma. <br /> 7. Support evidence-based withdrawal management services for people with OUD <br /> and any co-occurring mental health conditions. <br /> 15 As used in this Schedule B,words like"expand,""fund,""provide"or the like shall not indicate a preference for <br /> new or existing programs. <br /> E-4 <br />
The URL can be used to link to this page
Your browser does not support the video tag.